The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (13.40) USD. With the latest stock price at 8.08 USD, the upside of Neogenomics Inc based on DCF is -265.9%.
Based on the latest price of 8.08 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 265.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.0% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (37.87) - (8.94) | (13.40) |
| Upside | -568.7% - -210.7% | -265.9% |